Since others have reported that anti-estrogen therapy increases expression of the long-chain fatty acid carnitine acyltransferase CPT1A required for FA transport inside mitochondria (31), as well as the cell surface fatty acid transporter CD36 (44) in BC, we assessed whether enzalutamide affects either CPT1A or CD36 expression. This evidence concerns the gene CPT1A and breast cancer.